Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IPI≥2”

Showing 7 of 0 results

Not applicableStudy completedNCT02093455
What this trial is testing

Effects of Chardonnay Seed Flour on Vascular Health

Who this might be right for
1. Endothelial Dysfunction (EndoPAT Score <=2)
Mayo Clinic 168
Large-scale testing (Phase 3)UnknownNCT00435955
What this trial is testing

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Azienda Ospedaliera San Giovanni Battista 240
Not applicableWithdrawnNCT05131230
What this trial is testing

CytoSorb® in Patients With Acute on Chronic Liver Failure

Who this might be right for
Acute on Chronic Liver FailureAlcoholic Hepatitis
CytoSorbents Europe GmbH
Not applicableStudy completedNCT05699967
What this trial is testing

Development of an Automatically Generated and Wearable-based Early Warning System

Who this might be right for
Deterioration of Patient's State of Health
University Hospital, Basel, Switzerland 210
Not applicableStudy completedNCT01816386
What this trial is testing

Acupuncture Trial for Post Anaesthetic Recovery and Postoperative Pain

Who this might be right for
Laparoscopic Surgery of Uterus, Adnex or OvariesPostoperative Pain
Ludwig-Maximilians - University of Munich 75
Testing effectiveness (Phase 2)Ended earlyNCT04899921
What this trial is testing

Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets

Who this might be right for
MelanomaMetastatic Melanoma
Dana-Farber Cancer Institute 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731234
What this trial is testing

Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance

Who this might be right for
DLBCL
Fondazione Italiana Linfomi - ETS 75

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation